• No results found

[PDF] Top 20 Simultaneous Intravitreal Ranibizumab and Dexamethasone Implant Administration at the Same Setting in Eyes with Severe Diabetic Macular Edema

Has 10000 "Simultaneous Intravitreal Ranibizumab and Dexamethasone Implant Administration at the Same Setting in Eyes with Severe Diabetic Macular Edema" found on our website. Below are the top 20 most common "Simultaneous Intravitreal Ranibizumab and Dexamethasone Implant Administration at the Same Setting in Eyes with Severe Diabetic Macular Edema".

Simultaneous Intravitreal Ranibizumab and Dexamethasone Implant Administration at the Same Setting in Eyes with Severe Diabetic Macular Edema

Simultaneous Intravitreal Ranibizumab and Dexamethasone Implant Administration at the Same Setting in Eyes with Severe Diabetic Macular Edema

... the severe diabetic macular ...diffuse macular leakage, leakage related to NVE nasal to the disc peripheric retinal capillary nonperfusion areas (c) and composite fluorescein angiographic ... See full document

7

<p>Fluocinolone acetonide 0.19 mg intravitreal implant improves foveal thickness and reduces treatment burden for up to 1 year in eyes with persistent diabetic macular edema</p>

<p>Fluocinolone acetonide 0.19 mg intravitreal implant improves foveal thickness and reduces treatment burden for up to 1 year in eyes with persistent diabetic macular edema</p>

... or implant migration 17,19–27 . One strength of this study is the setting of a single private practice that covers the greater Cleveland area, which has a broad range of demographics and underlying disease ... See full document

9

Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema

Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema

... both eyes in terms of visual acuity (VA) and central macular thickness (CMT), and 3) underwent a therapeutic trial of the DEX implant in only one eye, were ... See full document

6

A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema

A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema

... aflibercept, ranibizumab or bevacizu- mab for DME was different but the relative efficacy depended on baseline ...and ranibizumab, especially among patients with an ini- tial baseline BCVA letter score of ... See full document

11

Effect of intravitreal aflibercept on recalcitrant diabetic macular edema

Effect of intravitreal aflibercept on recalcitrant diabetic macular edema

... being intravitreal anti-VEGF injections (excluding ...included intravitreal bevacizumab (IVB) and ranibizumab (IVR), intravitreal triamcinolone acetonide (IVTA), sub-Tenon’s triamci- nolone ... See full document

7

Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis

Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis

... The frequency of vitreous hemorrhage AESIs was higher in patients who received a larger number of on-study DEX injections (6.0% [95% CI, 3.5%–9.4%] in patients with .2 DEX injections vs 2.0% [95% CI, 1.1%–3.5%] in ... See full document

16

Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema

Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema

... fluocinolone, dexamethasone, and triamcinolone (Table ...and dexamethasone devices, with fewer patients achieving a BCVA improvement of $15 ...the dexamethasone insert, the percentage of eyes ... See full document

10

Dexamethasone intravitreal implant for the treatment of noninfectious uveitis

Dexamethasone intravitreal implant for the treatment of noninfectious uveitis

... an intravitreal device (dexamethasone or fluocinolone acetonide) were ...with dexamethasone implant (either ...mg dexamethasone implant, the 0.35 mg implant, and the sham ... See full document

9

Long-term follow-up of anatomical and functional macular changes after a single intravitreal implant of dexamethasone 0.7 mg for radiation macular edema secondary to proton beam therapy for choroidal melanoma

Long-term follow-up of anatomical and functional macular changes after a single intravitreal implant of dexamethasone 0.7 mg for radiation macular edema secondary to proton beam therapy for choroidal melanoma

... Recently, it has been hypothesized that the pathophysiol- ogy of radiation retinopathy could be comparable to that of diabetic retinopathy. As a matter of fact, they both are occlusive retinal microangiopathies in ... See full document

7

Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema

Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema

... Diabetic macular edema (DME) is the major cause of visual loss in working age patients in developed countries ...of intravitreal ranibizumab (IVR) (Lucentis, Novartis, Basel, ... See full document

6

Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study

Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study

... laser, intravitreal anti-VEGF, and intravitreal ...with ranibizumab is more effective than laser in improving vision in patients with DME [9, 10], and anti-VEGF injections have become preferred ... See full document

9

Critical appraisal of ranibizumab in the treatment of diabetic macular edema

Critical appraisal of ranibizumab in the treatment of diabetic macular edema

... receiving ranibizumab consistently achieved superior gains in vision compared with those randomized to sham, a finding that applied to all subtypes of diabetic patients, and to those who were previously ... See full document

11

Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema

Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema

... that intravitreal steroid therapy could significantly improve ME and visual ...of intravitreal steroids as a pos- sible treatment could be considered due to the inflam- matory pathogenic mechanism of CRVO, ... See full document

11

Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema

Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema

... receiving ranibizumab, after two mandatory injections, patients were reinjected on a prn basis according to vision stability and OCT ...with ranibizumab both as monotherapy or combined treatment were ... See full document

17

Evaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion

Evaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion

... What is very important, in the results of our study, is the fact that the treatment had no adverse effects on the amount and function of corneal endothelial cells measured by confocal microscopy. The analysis of density ... See full document

7

Intravitreal bevacizumab injections for diabetic macular edema &amp;ndash; predictors of response: a retrospective study

Intravitreal bevacizumab injections for diabetic macular edema &ndash; predictors of response: a retrospective study

... of intravitreal antivascular endothelial growth factor injections are variable among patients with diabetic macular edema ...to intravitreal bevacizumab ...78 eyes from 54 ... See full document

6

COMPARISON OF INTRAVITREAL BEVACIZUMAB (AVASTIN) WITH TRIAMCINOLONE FOR TREATMENT OF DIFFUSED DIABETIC MACULAR EDEMA: A PROSPECTIVE RANDOMIZED STUDYAli Kasiri, Fereydoun Farrahi, Mostafa Feghhi, Behnam Sadeghi, Hesam Hedayati, Seyed Ahmad Rasoulinejad DOW

COMPARISON OF INTRAVITREAL BEVACIZUMAB (AVASTIN) WITH TRIAMCINOLONE FOR TREATMENT OF DIFFUSED DIABETIC MACULAR EDEMA: A PROSPECTIVE RANDOMIZED STUDYAli Kasiri, Fereydoun Farrahi, Mostafa Feghhi, Behnam Sadeghi, Hesam Hedayati, Seyed Ahmad Rasoulinejad DOWNLOAD/VIEW

... of macular edema or inflammation during this ...of intravitreal steroids might exert certain protective effects against the initial deleterious events that follow grid laser treatment and might also ... See full document

9

Preliminary results of an intravitreal dexamethasone implant (Ozurdex&lt;sup&gt;&amp;reg;&lt;/sup&gt;) in patients with persistent diabetic macular edema

Preliminary results of an intravitreal dexamethasone implant (Ozurdex<sup>&reg;</sup>) in patients with persistent diabetic macular edema

... The study was conducted at the Policlinico Umberto I Hospital of “Sapienza” University of Rome. The eligibil- ity criteria were: age $18, a best-corrected visual acuity (BCVA) between 5 (corresponding to 1/10, logarithm ... See full document

6

Alternative treatment methods in eyes with pseudophakic cystoid macular edema

Alternative treatment methods in eyes with pseudophakic cystoid macular edema

... of macular edema treatment in which the mean central foveal thickness decreased from 598 ...another dexamethasone implant ...recurring macular edema had been completely reduced ... See full document

7

Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety

Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety

... Study design is prospective, comparative, randomized study, carried out at Army Hospital Research and Referral ophthalmology clinic between Sep-2012 and May-2014. The study is conducted in accordance with Declara- tion ... See full document

8

Show all 10000 documents...